NPI: 1760446199 · MONTGOMERY, AL 36106 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/13/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 04/13/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 10,005 | $142K |
| 2019 | 10,243 | $246K |
| 2020 | 10,459 | $211K |
| 2021 | 10,275 | $193K |
| 2022 | 9,669 | $109K |
| 2023 | 1,983 | $36K |
| 2024 | 287 | $4K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 18,001 | 1,339 | $751K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 17,827 | 1,005 | $158K |
| J1756 | Injection, iron sucrose, 1 mg | 3,398 | 759 | $19K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,691 | 838 | $6K |
| 83970 | 376 | 320 | $4K | |
| A4657 | Syringe, with or without needle, each | 729 | 642 | $914.00 |
| 85045 | 566 | 472 | $519.20 | |
| 85041 | 713 | 595 | $480.86 | |
| 85048 | 713 | 595 | $447.45 | |
| 82728 | 220 | 197 | $414.77 | |
| 83550 | 187 | 173 | $411.95 | |
| 83540 | 209 | 185 | $270.55 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 138 | 117 | $215.52 |
| 90674 | 32 | 29 | $142.85 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 106 | 37 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 15 | 14 | $0.00 |